| scholarly article | Q13442814 |
| P356 | DOI | 10.1034/J.1399-3003.1999.14C24.X |
| P698 | PubMed publication ID | 10543286 |
| P50 | author | Demosthenes Bouros | Q54130810 |
| P2093 | author name string | J Kottakis | |
| E Papadakis | |||
| N Siafakas | |||
| L Sichletidis | |||
| S Constantopoulos | |||
| P Pfister | |||
| M Froudarakis | |||
| N Bachlitzanakis | |||
| V Polychronopoulos | |||
| P433 | issue | 3 | |
| P921 | main subject | asthma | Q35869 |
| P304 | page(s) | 627-632 | |
| P577 | publication date | 1999-09-01 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Formoterol and beclomethasone versus higher dose beclomethasone as maintenance therapy in adult asthma | |
| P478 | volume | 14 |
| Q35879025 | A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease |
| Q24794527 | Add-on therapy options in asthma not adequately controlled by inhaled corticosteroids: a comprehensive review |
| Q24245719 | Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults |
| Q24240464 | Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children |
| Q24235303 | Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children |
| Q24235964 | Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma |
| Q51146642 | Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. |
| Q24245383 | Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma |
| Q24194706 | Combined corticosteroid and long-acting beta-agonist in one inhaler for chronic asthma |
| Q44523467 | Formoterol (Foradil) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma |
| Q42607166 | Formoterol 12 microg BID administered via single-dose dry powder inhaler in adults with asthma suboptimally controlled with salmeterol or on-demand salbutamol: a multicenter, randomized, open-label, parallel-group study |
| Q90280808 | Inhaled steroids with and without regular formoterol for asthma: serious adverse events |
| Q38043452 | Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation. |
| Q24245643 | Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma |
| Q36246222 | Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma. |
| Q24202005 | Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events |
| Q24241453 | Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events |
| Q34523194 | Safety of inhaled corticosteroids in children |
| Q36419451 | The role of inhaled long-acting beta-2 agonists in the management of asthma |
| Q35615221 | Tolerability of short-term, high-dose formoterol in healthy volunteers and patients with asthma |
Search more.